Kezar Life Sciences, Inc. (KZR)
7.29
0.00 (0.00%)
USD |
NASDAQ |
Aug 21, 16:00
Kezar Life Sciences 1 Year Total Returns (Daily) : 84.56% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 84.56% |
| August 20, 2026 | 86.92% |
| August 19, 2026 | 87.89% |
| August 18, 2026 | 88.86% |
| August 17, 2026 | 83.63% |
| August 14, 2026 | 83.17% |
| August 13, 2026 | 85.97% |
| August 12, 2026 | 86.92% |
| August 11, 2026 | 85.50% |
| August 10, 2026 | 82.02% |
| August 07, 2026 | 83.17% |
| August 06, 2026 | 77.80% |
| August 05, 2026 | 79.12% |
| August 04, 2026 | 77.80% |
| August 03, 2026 | 80.00% |
| July 31, 2026 | 70.73% |
| July 30, 2026 | 69.93% |
| July 29, 2026 | 68.36% |
| July 28, 2026 | 67.20% |
| July 27, 2026 | 69.14% |
| July 24, 2026 | 63.09% |
| July 23, 2026 | 69.53% |
| July 22, 2026 | 63.82% |
| July 21, 2026 | 69.53% |
| July 20, 2026 | 67.59% |
| Date | Value |
|---|---|
| July 17, 2026 | 63.45% |
| July 16, 2026 | 62.00% |
| July 15, 2026 | 57.79% |
| July 14, 2026 | 59.17% |
| July 13, 2026 | 61.64% |
| July 10, 2026 | 52.19% |
| July 09, 2026 | 59.17% |
| July 08, 2026 | 60.93% |
| July 07, 2026 | 60.22% |
| July 06, 2026 | 59.17% |
| July 02, 2026 | 62.36% |
| July 01, 2026 | 65.68% |
| June 30, 2026 | 59.17% |
| June 29, 2026 | 64.19% |
| June 26, 2026 | 70.73% |
| June 25, 2026 | 78.24% |
| June 24, 2026 | 64.56% |
| June 23, 2026 | 71.13% |
| June 22, 2026 | 61.28% |
| June 18, 2026 | 63.45% |
| June 17, 2026 | 78.24% |
| June 16, 2026 | 67.97% |
| June 15, 2026 | 58.82% |
| June 12, 2026 | 52.19% |
| June 11, 2026 | 55.44% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| NovelStem International Corp. | -47.22% |
| Brainstorm Cell Therapeutics, Inc. | 55.31% |
| Summit Therapeutics, Inc. | -49.40% |
| Protara Therapeutics, Inc. | 24.19% |
| Clene, Inc. | -19.10% |